Spiramide (developmental code name AMI-193) is an experimental antipsychotic that acts as a selective 5-HT2A, 5-HT1A, and D2 receptor antagonist. It has negligible affinity for the 5-HT2C receptor.[1][2][3]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
IUPHAR/BPS |
|
ChemSpider |
|
UNII |
|
ChEBI |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C22H27FN3O2 |
Molar mass | 384.475 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(verify) |